Regulus Therapeutics Inc. (RGLS) Other Assets, Noncurrent USD 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Regulus Therapeutics Inc. quarterly Other Assets, Noncurrent history and growth rate from 2011 to 2024.
  • Regulus Therapeutics Inc. Other Assets, Noncurrent for the quarter ending March 31, 2024 was $74 K.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $74 K Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $0 $0 Dec 31, 2023 10-Q 2024-05-09
Q4 2022 $0 -$291 K -100% Dec 31, 2022 10-K 2023-03-23
Q3 2022 $0 $0 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $0 $0 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $148 K +$148 K Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $291 K +$267 K +1113% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $0 -$333 K -100% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $0 -$387 K -100% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $0 -$439 K -100% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $24 K -$463 K -95.1% Dec 31, 2020 10-K 2022-03-11
Q3 2020 $333 K -$203 K -37.9% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $387 K +$360 K +1333% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $439 K +$306 K +230% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $487 K +$161 K +49.4% Dec 31, 2019 10-K 2021-03-09
Q3 2019 $536 K +$209 K +63.9% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $27 K -$301 K -91.8% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $133 K -$487 K -78.5% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $326 K -$264 K -44.7% Dec 31, 2018 10-K 2020-03-12
Q3 2018 $327 K +$20 K +6.52% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $328 K -$12 K -3.53% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $620 K +$285 K +85.1% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $590 K +$248 K +72.5% Dec 31, 2017 10-K 2019-03-18
Q3 2017 $307 K -$36 K -10.5% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $340 K +$30 K +9.68% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 $335 K -$19 K -5.37% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $342 K -$2 K -0.58% Dec 31, 2016 10-K 2018-03-08
Q3 2016 $343 K -$1.73 M -83.5% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 $310 K -$1.48 M -82.7% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 $354 K -$1.45 M -80.3% Mar 31, 2016 10-Q 2016-05-03
Q4 2015 $344 K -$1.47 M -81% Dec 31, 2015 10-K 2017-03-03
Q3 2015 $2.08 M +$1.04 M +100% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $1.79 M +$817 K +83.6% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $1.8 M +$822 K +84% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $1.81 M +$824 K +83.5% Dec 31, 2014 10-K 2016-02-23
Q3 2014 $1.04 M +$860 K +483% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $977 K +$573 K +142% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $978 K +$788 K +415% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $987 K +$862 K +690% Dec 31, 2013 10-K 2015-02-19
Q3 2013 $178 K -$1.92 M -91.5% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $404 K Jun 30, 2013 10-Q/A 2013-08-16
Q1 2013 $190 K Mar 31, 2013 10-Q 2013-05-15
Q4 2012 $125 K $0 0% Dec 31, 2012 10-K 2014-02-28
Q3 2012 $2.1 M Sep 30, 2012 10-Q 2012-11-19
Q4 2011 $125 K Dec 31, 2011 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.